Fellow, Ending Bioweapons Program
Riley Griffin is a health reporter for Bloomberg News who covers biosecurity and pandemic preparedness. Based in Washington, Riley is focused on how U.S. government agencies, from the Department of Health and Human Services to the Defense Department, are working with industry, academia and nonprofits to counter a range of naturally-occurring, accidental and deliberate health threats. From 2018 through 2022, Riley covered the largest players in the U.S. pharmaceutical industry and their efforts to develop medical countermeasures for Covid-19. She was awarded a Front Page Award for beat reporting on the pandemic. Riley graduated magna cum laude from Duke University, where she studied international relations, policy journalism and English. There, she won the Sanford School of Public Policy’s Melcher Award for excellence in journalism. Riley has written for HuffPost and The Poynter Institute, and helped research and edit books published by historians and novelists.
